Stocks to sell

Cannabis company Tilray (NASDAQ:TLRY) is undeniably a disappointment. Meme traders sent TLRY stock to an unsustainable high of $67 in February. Since then, the stock has fallen steadily. Source: Jarretera / Shutterstock.com As this Canadian cannabis firm aims to expand to the U.S., should the owners of its stock hold onto their shares? The Bearish
0 Comments
Lemonade (NASDAQ:LMND) stock has caught investors’ attention, and for pretty good reason. Source: Stephanie L Sanchez / Shutterstock.com If Amazon’s (NASDAQ:AMZN) taught us anything over the past few decades, it’s the power of disruption, and the value of recognising it early. That’s part of the reason that insurance disruptor Lemonade is so attractive. LMND stock
0 Comments
It is no secret that Hyliion Holdings (NYSE:HYLN) stock has become a massive disappointment. Source: Hyliion media It fell dramatically leading up to its special purpose acquisition company (SPAC) merger back in late 2020, after rising in equally dramatic fashion after the initial announcement.  Prices rocketed from under $10 per share to a high nearing
0 Comments
After months of sideways price action, Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock is zooming higher once. Source: shutterstock.com/PhotobyTawat The big development is a likely Emergency Use Listing (EUL) from the World Health Organization (WHO) for Covaxin. Developed in India by Bharat Biotech, Ocugen holds the U.S. and Canadian rights to market this vaccine. An EUL certainly
0 Comments
Just over a year ago, Hyliion (NYSE:HYLN) was one of the hottest electric vehicle special-purpose acquisition company (SPAC) plays out there. Just before its “de-SPACing,” excitement over this maker of electric trucks and powertrains briefly sent HYLN stock to prices over $50 per share. Source: Shutterstock Flash forward back to now, and where are shares changing
0 Comments